SEK143.20
0.00%
Stockholm, Tue, Jul 22 2025
ISIN
SE0000454746
Symbol
BIOT

Key metrics

Basic
Market capitalization
SEK11.4b
Enterprise Value
SEK11.3b
Net debt
positive
Cash
SEK420.0m
Shares outstanding
80.1m
Valuation (TTM | estimate)
P/E
- | -
P/S
5.8 | 5.4
EV/Sales
5.7 | 5.3
EV/FCF
59.9
P/B
3.0
Dividends
DPS
SEK1.65
Yield 1Y | 5Y
1.2% | 0.9%
Growth 1Y | 5Y
3.1% | -
Payout 1Y | 3Y
46.5% | 44.4%
Increased
1 Year
Financials (TTM | estimate)
Revenue
SEK2.0b | SEK2.1b
EBITDA
SEK507.0m | SEK532.4m
EBIT
SEK327.0m | SEK352.9m
Net Income
SEK255.0m | SEK265.0m
Free Cash Flow
SEK188.0m
Growth (TTM | estimate)
Revenue
-1.5% | 2.6%
EBITDA
2.4% | -1.4%
EBIT
0.0% | -4.1%
Net Income
8.1% | -6.7%
Free Cash Flow
-29.9%
Margin (TTM | estimate)
Gross
62.6%
EBITDA
25.9% | 25.3%
EBIT
16.7%
Net
13.0% | 12.6%
Free Cash Flow
9.6%
Financial Health
Equity Ratio
80.6%
Return on Equity
6.9%
ROCE
7.7%
ROIC
7.4%
Debt/Equity
0.1
More
EPS
SEK3.2
FCF per Share
SEK2.3
Short interest
-
Employees
622
Rev per Employee
SEK3.3m
Show more

Is Biotage AB a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,025 stocks worldwide.

Biotage AB Stock Analysis

Unlock Scores for Free

Analyst Opinions

10 Analysts have issued a Biotage AB forecast:

4x Hold
40%
6x Sell
60%

Analyst Opinions

10 Analysts have issued a Biotage AB forecast:

Hold
40%
Sell
60%

Financial data from Biotage AB

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Mar '25
+/-
%
1,961 1,961
2% 2%
100%
- Direct Costs 733 733
2% 2%
37%
1,228 1,228
1% 1%
63%
- Selling and Administrative Expenses 780 780
10% 10%
40%
- Research and Development Expense 180 180
3% 3%
9%
507 507
2% 2%
26%
- Depreciation and Amortization 180 180
7% 7%
9%
EBIT (Operating Income) EBIT 327 327
0% 0%
17%
Net Profit 255 255
8% 8%
13%

In millions SEK.

Don't miss a Thing! We will send you all news about Biotage AB directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Biotage AB engages in the provision of separation and synthesis technology solutions. Its products and services include sample preparation, horizon food and environmental products, organic synthesis, peptide chemistry, flash purification, work-up products, evaporation and concentration, and service and support. The company was founded by Pal Nyren, Carl Erik Mathias Uhlen, Mostafa Ronaghi, Bertil Pettersson, Neil Goldsmith and Bjorn Ekstrom in 1969 and is headquartered in Uppsala, Sweden.

Head office Sweden
CEO Mr. Vanderhaegen
Employees 622
Founded 1997
Website www.biotage.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today